Aurobindo Pharma secures USFDA approval for Glycerol Phenylbutyrate Oral Liquid
Company to launch product for urea cycle disorders with market size of US$ 50.2 million
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Alembic Pharma gets USFDA nod for Methotrexate Injection USP, 50 mg/2 mL multi-dose vials and 1g/40…
Methotrexate Injection is a folate analog metabolic inhibitor indicated for neoplastic diseases
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
The shift reflects intensifying demand for metabolic therapies and growing logistics risk, signaling a structural move toward…
Rubicon Research acquires 85% stake in Arinna Lifesciences
Transaction valued at INR 200 crore to expand presence in CNS therapies and domestic formulations market
Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India
New pricing for weight management drug effective from April 3, 2026
Aurigene and Alveus Therapeutics advance collaboration with ALV-200 candidate nomination
Partnership supports drug discovery programmes for obesity and metabolic disease
MSN Laboratories launches SEMABEST semaglutide in India after CDSCO approval
Product priced lower than innovator drug and introduced for type 2 diabetes treatment
Sun Pharma launches brand film with Royal Challengers Bengaluru
Campaign highlights association as principal sponsor and health partner during T20 season
Orbicular, Gland Pharma and Apotex secure US FDA approval for generic INFUVITE ADULT injectable
ANDA approval with CGT designation grants six-month exclusivity for parenteral nutrition product in the United States
Novo Nordisk announces partnership with OpenAI
Partnership applies AI to drug discovery and operations across Novo Nordisk and OpenAI programmes